The WOC Skin Health Weekly®, a weekly e-news publication packed with career empowerment resources including the latest clinical, industry, and product news, clinical education, market research, and of course, the most recently posted jobs requiring expertise in the prevention and treatment of skin breakdown and wound care. Over 20,000 clinicians now receive the WOC Skin Health Weekly.
Receive your own complimentary subscription to the WOC Skin Health Weekly®
Humans are currently locked in an arms race against pathogenic bacteria – and we're losing. After we developed antibiotics, starting with penicillin in the early 20th century, bacteria have evolved resistance to each new drug we created, threatening us with a future where antibiotics simply don't work anymore. Now scientists have identified the genes responsible for antibiotic resistance in a particularly dangerous superbug, and found a way to thwart them. Read More
Allergan will be acquired by AbbVie for approximately $63 billion in cash and stock, the two companies announced in a press release. Under a definitive transaction agreement, which has been signed by both entities, Allergan shareholders will receive 0.8660 AbbVie shares and $120.30 in cash for each Allergan share they hold. "This acquisition creates compelling value for Allergan's stakeholders, including our customers, patients and shareholders. With 2019 annual combined revenue of approximately $48 billion, scale in more than 175 countries, an industry-leading R&D pipeline and robust cash flows, our combined company will have the opportunity to make even bigger contributions to global health than either can alone," Brent Saunders, Allergan chairman and CEO, said. Read More
Obesity Increases a Patient’s Risk for Developing a Surgical Site Infection, or Ssi, Although the Extent of Impact Depends on the Type of Surgery, According to a Recent Study Conducted in the Netherlands. “the Prevalence of Obesity Is Growing Worldwide and Is Reaching Epidemic Proportions in Developed Countries,” Anouk P. Meijs, Msc, from the Centre for Infectious Disease Control in the Netherlands’ National Institute for Public Health and the Environment, and Colleagues Wrote. Read More
Patients colonized with Candida auris carry a high burden of the emerging and often multidrug-resistant fungal pathogen on their skin, suggesting that the natural process of skin shedding among these patients leads to contamination of the heath care environment and contributes to transmission, according to findings presented at ASM Microbe. C. auris presents a public health concern because of its ability to cause large and persistent outbreaks, such as the outbreak in New York City hospitals. The specific mechanisms of transmission are not clear, which makes controlling these outbreaks difficult, according to Joe Sexton, PhD, a postdoctoral fellow in the CDC’s Mycotic Diseases Branch, and colleagues. Read More